申请人:Merck Frosst Canada, Inc.
公开号:US04634766A1
公开(公告)日:1987-01-06
Compounds of the Formula I: ##STR1## are inhibitors of the mammalian 5-lipoxygenase enzyme system of the arachidonic acid cascade. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders and inflammation.
公式为I的化合物:##STR1## 是阻止花生四烯酸级联反应中哺乳动物5-脂氧合酶酶系统的抑制剂。因此,这些化合物是治疗过敏症、哮喘、心血管疾病和炎症的有用治疗药物。